Lineage Cell Therapeutics (LCTX)

Q4 2020 EPS: Catalysts Rich 2021 Ahead

March 12, 2021
Report ID: 12128
Already Registered?
Click the Get Report button to login and view the full report, with price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ā€˜Get Reportā€™ button to login and view the research report.

Not a Member? Register Now to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

Ticker
LCTX
Current Price
$0.676 -2.52%
Market Cap
$127.7M
Price Target
Refer to Report
Volume
755.8K
52wk Range
$0.481 - $1.61
Ā© 2018-2025 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.